Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients  Colin R. Lenihan, MB BCh, PhD, Sumi Sukumaran Nair, MD, Chandan Vangala, MD, Venkat Ramanathan, MD, Maria E. Montez-Rath, PhD, Wolfgang C. Winkelmayer, MD, ScD  American Journal of Kidney Diseases  Volume 69, Issue 5, Pages 595-601 (May 2017) DOI: 10.1053/j.ajkd.2016.09.019 Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Multivariable association between hip fracture versus control status and prior proton pump inhibitor (PPI) use. Odds ratios and corresponding 95% confidence intervals (CIs) were estimated from case-control sets that were matched on age, sex, race, and time since transplantation using a conditional logistic regression model with adjustment for all other variables listed in Table 1. Lesser PPI use was defined as <80% of days covered with prescribed PPI in the year prior to index; higher use was ≥80% of days covered. American Journal of Kidney Diseases 2017 69, 595-601DOI: (10.1053/j.ajkd.2016.09.019) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions